National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-1-amino-3-[18F ]fluorocyclobutane-1-carboxylic acid
A radiotracer containing a synthetic amino acid analogue of L-leucine radiolabeled with fluorine F 18 with potential diagnostic imaging use. Similar to most amino acids, anti-1-amino-3-[18F]fluorocyclobutane-1-carboxylic acid ([18]FACBC) appears to enter cells through the energy-independent L-type amino acid transporter (LAT) system. As an amino acid analogue, this agent is preferentially accumulated by tumor cells due to their increased metabolic needs; however, unlike naturally occuring amino acids, this non-natural amino acid-analogue radiotracer is not metabolized. Accordingly, [18]FACBC accumulates in tumor cells and can potentially be used to image tumors using positron emission tomography (PET). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:[18F]FACBC



Previous:aniline mustard, annamycin liposomal, Ansaid, Antabuse, anthracycline analogue GPX-150
Next:anti-B4 blocked ricin immunotoxin, anti-CCL-2 human monoclonal antibody CNTO 888, anti-CD137 monoclonal antibody, anti-CD19 fully human monoclonal antibody MDX-1342, anti-CD19-DM4 immunoconjugate SAR3419

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov